Skip to the page

Data / Drug companies / Aurobindo Pharma Limited

Aurobindo Pharma Limited: 102 products in the FDA NDC directory, labeler code 84386

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Aurobindo Pharma Limited (labeler code 84386) lists 102 products in the FDA National Drug Code Directory, covering 19 finished drugs by generic name. By type: 45 prescription drugs, 40 bulk ingredients. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 26, 2026.

The request: Watch Aurobindo Pharma Limited (FDA labeler code 84386): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84386
Products in commercial distribution
102
Packages
163
Finished drugs by generic name
19
Prescription products
45
Over the counter products
4
Controlled substance products
Schedule III 6, Schedule IV 2, Schedule V 6
Flagged as original packager
27 of 27 products that carry the flag
Started marketing in the last 12 months
75
Earliest marketing start
January 22, 2024
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)4847.1%
Bulk ingredients4039.2%
Drugs for further processing1312.7%
Authorized generics (NDA)11%

Products by type

TypeProductsShare
Prescription drugs4544.1%
Bulk ingredients4039.2%
Drugs for further processing1312.7%
Over the counter drugs43.9%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Powder4039.2%
Tablet, film coated3534.3%
Tablet1514.7%
Powder, for solution32.9%
Capsule32.9%
Granule22%
Tablet, film coated, extended release22%
Gel11%
Cream11%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sacubitril and Valsartan84386-083Tablet, film coatedGeneric drugs (ANDA)October 26, 2026
Sacubitril and Valsartan84386-082Tablet, film coatedGeneric drugs (ANDA)October 26, 2026
Sacubitril and Valsartan84386-081Tablet, film coatedGeneric drugs (ANDA)October 26, 2026
Rasagiline84386-170TabletGeneric drugs (ANDA)October 20, 2026
Rasagiline84386-169TabletGeneric drugs (ANDA)October 20, 2026
Canagliflozin hemihydrate (process-ii)84386-234PowderBulk ingredientsOctober 12, 2026
Perampanel84386-089Tablet, film coatedGeneric drugs (ANDA)October 2, 2026
Perampanel84386-088Tablet, film coatedGeneric drugs (ANDA)October 2, 2026
Perampanel84386-087Tablet, film coatedGeneric drugs (ANDA)October 2, 2026
Perampanel84386-086Tablet, film coatedGeneric drugs (ANDA)October 2, 2026
Perampanel84386-085Tablet, film coatedGeneric drugs (ANDA)October 2, 2026
Perampanel84386-084Tablet, film coatedGeneric drugs (ANDA)October 2, 2026
Polyethylene glycol 335084386-150Powder, for solutionDrugs for further processingSeptember 28, 2026
Auropap 90f (acetaminophen directly compressible granules) process-ii84386-233GranuleDrugs for further processingSeptember 16, 2026
Isotretinoin84386-011CapsuleGeneric drugs (ANDA)September 10, 2026
Isotretinoin84386-010CapsuleGeneric drugs (ANDA)September 10, 2026
Isotretinoin84386-009CapsuleGeneric drugs (ANDA)September 10, 2026
Pravastatin sodium84386-167TabletGeneric drugs (ANDA)September 4, 2026
Cilostazol84386-003TabletGeneric drugs (ANDA)September 3, 2026
Cilostazol84386-002TabletGeneric drugs (ANDA)September 3, 2026
Tizanidine84386-024TabletGeneric drugs (ANDA)September 1, 2026
Tizanidine84386-023TabletGeneric drugs (ANDA)September 1, 2026
Trofinetide84386-217PowderBulk ingredientsAugust 5, 2026
Atenolol84386-219PowderBulk ingredientsJuly 31, 2026
Sparsentan84386-218PowderBulk ingredientsJuly 31, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.